Findings

What do systematic reviews say?

194 questions · 239 findings · 32 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 46 · 19.2%GRADE not reported 18 · 7.5%Very low 36 · 15.1%Low 56 · 23.4%Moderate 58 · 24.3%High 25 · 10.5%

Intervention not reported

Effect on quality of life of child and family · Children with cerebral palsy

The review found no eligible studies for this question.

1 finding from 1 review

Sleep positioning systems for children with cerebral palsy 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Effect on pain · Children with cerebral palsy

1 finding from 1 review

Sleep positioning systems for children with cerebral palsy 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 10 participants
Very low

Intervention not reported

Effect on physical functioning · Children with cerebral palsy

The review found no eligible studies for this question.

1 finding from 1 review

Sleep positioning systems for children with cerebral palsy 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Adverse effects · Children with cerebral palsy

The review found no eligible studies for this question.

1 finding from 1 review

Sleep positioning systems for children with cerebral palsy 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

BoNT‐A vs placebo/no treatment

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Moderate

BoNT‐A/OT vs OT only

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 84 participants
High

BoNT‐A/OT vs OT only

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 69 participants
High

BoNT‐A/OT vs OT only

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 152 participants
High

BoNT‐A/OT vs OT only

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 109 participants
High

BoNT‐A/OT vs OT only

Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 109 participants
High

BoNT‐A/OT vs BoNT‐A only

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
High

BoNT‐A/OT vs BoNT‐A only

Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 14 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
High

BoNT‐A/OT vs BoNT‐A only

Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
High

BoNT‐A vs placebo/no treatment

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs BoNT‐A only

Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · patients with children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

BoNT‐A/OT vs placebo/no treatment

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 35 participants
Moderate

BoNT‐A/OT vs placebo/no treatment

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · children with cerebral palsy

1 finding from 1 review

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral… 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 35 participants
High